Condition: Retinopathy of Prematurity · Sponsor: Duke University
Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. This study tests high-speed optical coherence tomography (OCT) technology compared to conventional color photographs at the bedside of very preterm infants in the intensive care nursery, to characterize previously unseen abnormalities that can predict a need for referral for ROP treatment, or poor visual or neurological development later in life, up to pre-school age. Our long-term goal is to help improve preterm infant health and vision via objective bedside imaging and analysis that characterizes early critical indicators of ROP, and poor visual function and neurological development, which will rapidly translate to better early intervention and improved future care.
This description comes directly from the study's public registry record.
Cynthia A Toth, MD · 919-684-5631 · cynthia.toth@duke.edu
Michelle N McCall, MCAPM, BA · 919-684-0544 · michelle.mccall@duke.edu
Always discuss trial participation with your own doctor first.
| Duke University Eye Center | Durham, North Carolina, United States | Recruiting |
| University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics | Philadelphia, Pennsylvania, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04995341